News & Updates

Show Multimedia Only

Life quality poorer in COVID-19 survivors with ongoing symptoms

13 May 2025 by

In adults who have survived the COVID-19 pandemic, health-related quality of life (HRQoL) is high among those who had either recovered from post-COVID-19 condition (PCC) or had never been afflicted with PCC, according to a study.

Life quality poorer in COVID-19 survivors with ongoing symptoms

13 May 2025

TAF prophylaxis prevents mother-to-child transmission of HBV

13 May 2025

Treatment with tenofovir alafenamide (TAF) is generally safe and effective for the prevention of hepatitis B virus (HBV) mother-to-child transmission (MTCT), reports a study, noting that the expected 8-week prenatal duration is feasible.

TAF prophylaxis prevents mother-to-child transmission of HBV

13 May 2025

Monoclonal antibodies vs COVID-19 up risks of hepatotoxicity, neutropenia

08 May 2025 by

Treatment with monoclonal antibodies (mAbs) among COVID-19 patients is associated with a higher risk of hepatotoxicity and neutropenia when compared with standard of care (SoC) or placebo, reports a study.

Monoclonal antibodies vs COVID-19 up risks of hepatotoxicity, neutropenia

08 May 2025

Rapid point-of-care testing enables timely and targeted RTI treatment

07 May 2025

According to the 2021 Global Burden of Disease (GBD) study, COVID-19 and lower respiratory tract infections (LRTIs) ranked as the 1st and 5th leading causes of global disease burden across all age groups and genders.

Rapid point-of-care tests (POCTs) enable timely diagnosis, particularly in vulnerable populations at higher risk of severe illness, complications, and hospitalization.

Rapid point-of-care testing enables timely and targeted RTI treatment

07 May 2025

Single-dose RSVPreF3 OA vaccine effective over 3 RSV seasons in seniors

07 May 2025 by

A single dose of adjuvanted respiratory syncytial virus (RSV) prefusion F protein–based vaccine (RSVPreF3 OA) is efficacious against RSV-related lower respiratory tract disease (RSV-LRTD) over three RSV seasons in older adults aged ≥60 years, according to results of the phase III AReSVi-006 trial presented at ESCMID Global 2025.

Single-dose RSVPreF3 OA vaccine effective over 3 RSV seasons in seniors

07 May 2025

Single primaquine dose helps block malaria transmission in children

06 May 2025

A single low primaquine dose appears to safely and efficaciously reduce transmission of Plasmodium falciparum in children, according to the results of a meta-analysis.

Single primaquine dose helps block malaria transmission in children

06 May 2025

BNT162b2 JN.1-adapted vaccine effective against COVID-19 hospitalization

06 May 2025 by

BNT162b2 JN.1-adapted vaccine provides protection against COVID-19–related hospitalization in Europe, a case-control study using the id.DRIVE platform has shown.

BNT162b2 JN.1-adapted vaccine effective against COVID-19 hospitalization

06 May 2025

More than half of UTIs treated inappropriately in primary care in SG

05 May 2025 by

New research from Singapore has shown that most patients with uncomplicated urinary tract infections (UTIs) being treated in primary care receive inappropriate antibiotics.

More than half of UTIs treated inappropriately in primary care in SG

05 May 2025

การฉีดวัคซีนเป็นกลยุทธ์สำคัญในการป้องกันและควบคุมไข้เลือดออกในภูมิภาคเอเชียตะวันออกเฉียงใต้

03 May 2025

เอเชียตะวันออกเฉียงใต้ (Southeast Asia; SEA) เป็นพื้นที่เสี่ยงติดเชื้อไข้เลือดออก โดยอินโดนีเซียและไทยเป็นประเทศที่พบการระบาดสูง ในงานสัมมนาระหว่างการประชุมสุดยอด APIC-ADVA ประจำภูมิภาคเอเชียแปซิฟิกครั้งที่ 2 ว่าด้วยโรคติดเชื้อและการสร้างภูมิคุ้มกัน ณ ประเทศสิงคโปร์ สนับสนุนโดยบริษัท Takeda ผู้เชี่ยวชาญได้เน้นย้ำถึงการฉีดวัคซีน ซึ่งเป็นส่วนสำคัญของกลยุทธ์สำหรับการป้องกันและควบคุมไข้เลือดออกแบบองค์รวมในภูมิภาค SEA

การฉีดวัคซีนเป็นกลยุทธ์สำคัญในการป้องกันและควบคุมไข้เลือดออกในภูมิภาคเอเชียตะวันออกเฉียงใต้

03 May 2025

Ibrexafungerp expands salvage antifungal treatment options as a pill

03 May 2025 by

For patients with fungal diseases that preclude receiving standard treatment or IV antifungals primarily due to refractoriness or resistance, ibrexafungerp can serve as an effective salvage treatment given orally, offering a positive risk-benefit ratio up to the final data cut-off in the FURI trial

Ibrexafungerp expands salvage antifungal treatment options as a pill

03 May 2025

News & Updates

Filter by Specialty:

Specialty:

Life quality poorer in COVID-19 survivors with ongoing symptoms

Life quality poorer in COVID-19 survivors with ongoing symptoms

TAF prophylaxis prevents mother-to-child transmission of HBV

TAF prophylaxis prevents mother-to-child transmission of HBV

Monoclonal antibodies vs COVID-19 up risks of hepatotoxicity, neutropenia

Monoclonal antibodies vs COVID-19 up risks of hepatotoxicity, neutropenia

Rapid point-of-care testing enables timely and targeted RTI treatment

Rapid point-of-care testing enables timely and targeted RTI treatment

Single-dose RSVPreF3 OA vaccine effective over 3 RSV seasons in seniors

Single-dose RSVPreF3 OA vaccine effective over 3 RSV seasons in seniors

Single primaquine dose helps block malaria transmission in children

Single primaquine dose helps block malaria transmission in children

BNT162b2 JN.1-adapted vaccine effective against COVID-19 hospitalization

BNT162b2 JN.1-adapted vaccine effective against COVID-19 hospitalization

More than half of UTIs treated inappropriately in primary care in SG

More than half of UTIs treated inappropriately in primary care in SG

การฉีดวัคซีนเป็นกลยุทธ์สำคัญในการป้องกันและควบคุมไข้เลือดออกในภูมิภาคเอเชียตะวันออกเฉียงใต้

การฉีดวัคซีนเป็นกลยุทธ์สำคัญในการป้องกันและควบคุมไข้เลือดออกในภูมิภาคเอเชียตะวันออกเฉียงใต้

Ibrexafungerp expands salvage antifungal treatment options as a pill

Ibrexafungerp expands salvage antifungal treatment options as a pill